Metabolic disorders and hepatitis: Insights from a Mendelian randomization study

Area of Science:

• Genetics
• Hepatology
• Metabolic Disorders

Background:

• Hepatitis is a systemic disease frequently associated with comorbidities.
• Metabolic disorders are common clinical comorbidities observed in hepatitis patients.

Purpose of the Study:

• To investigate the potential causal relationship between metabolic comorbidities and hepatitis treatment outcomes.
• To explore the influence of type 2 diabetes mellitus, hyperlipidemia, and hypertension on chronic hepatitis B and C infections.

Main Methods:

• Utilized a two-sample Mendelian randomization (MR) approach.
• Analyzed single nucleotide polymorphism data from large-scale genome-wide association studies (GWAS).
• Examined causality between exposures (T2D, hyperlipidemia, hypertension) and outcomes (chronic hepatitis B or C).

Main Results:

• Supported a causal relationship between metabolic comorbidities and hepatitis infections.
• Identified links between type 2 diabetes mellitus, hyperlipidemia, and hypertension with the progression of both hepatitis B and C.
• Hypertension showed a statistically significant association with hepatitis C progression (P = 0.035).

Conclusions:

• Mendelian randomization results suggest a possible causal link between type 2 diabetes mellitus, hyperlipidemia, and hypertension, and chronic hepatitis progression.
• The underlying biological mechanisms require further investigation.
• Findings provide a reference for clinical researchers studying hepatitis comorbidities.